Fabian Theis recalls that Parse Biosciences had an initiative he thinks was called the GigaLab, and says competing companies now have similar efforts.

“And you know, when I started my career early on, we had like a few bug RNA. Now we sort of had thousands of them or whatever, right? So this is like early times. But now, you know, we, we go into to a regime, and that was sort of one of these eye-opening moments when, when Pars Bio had like, I think they call it the GigaLab or something like that, and you know, there's sort of similar ones from competing companies now.”